News Rising UK drugs bill raises fears of price controls Higher than expected growth in the branded medicines bill has caused the UK government to consider price cuts.
News A vote of no confidence in UK's pricing system The new PPRS is not good news for all pharma companies, concludes industry audience
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
